|
|
|
|
| LEADER |
03495nam a22003135i 4500 |
| 001 |
978-3-642-68041-0 |
| 005 |
20180829122952.0 |
| 007 |
cr nn 008mamaa |
| 008 |
121227s1981 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642680410
|
| 024 |
7 |
|
|a 10.1007/978-3-642-68041-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Creatine Kinase Isoenzymes
|b Pathophysiology and Clinical Application /
|c edited by Hermann Lang.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg,
|c 1981.
|
| 300 |
|
|
|a XVIII, 317 p. 24 illus.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a 1 Introduction -- 1.1 Creatine Kinase in Muscular Metabolism -- 1.2 Creatine Kinase in Clinical Chemistry -- 1.3 Creatine Kinase Isoenzymes -- 1.4 Scope and Summary of this Book -- 2 Creatine Kinase Isoenzymes -- 2.1 The Cytoplasmic Isoenzymes from Human Tissues -- 2.2 The Mitochondrial Isoenzyme from Human Heart Muscle -- 3 Methods for Differentiation and Quantitation of Creatine Kinase Isoenzymes -- 3.1 Methods for Determination of Creatine Kinase Activity -- 3.2 Differentiation of Isoenzymes by Non Immunological Methods. -- 3.3 Measurement of Isoenzyme Activity by Immunological Methods. -- 3.4 Experimental Comparison of Methods for Differentiation of Isoenzymes -- 3.5 Measurement of Isoenzyme Concentration by Immunoassay. -- 4 Tissue Specific and Subcellular Distribution of Creatine Kinase Isoenzymes -- 4.1 Tissue Specific Distribution -- 4.2 Subcellular Distribution -- 4.3 Ontogeny -- 5 Clinical Results: Myocardium -- 5.1 Myocardial Infarction -- 5.2 Infarct Size Estimation from Serial Analyses of CK and Isoenzyme Activity. -- 5.3 Perioperative Infarction -- 5.4 Complications, Differential Diagnosis, and Diagnostic/ Therapeutic Procedures Associated with Myocardial Infarction. -- 5.5 Heart Failure and Inflammation. -- 6 Clinical Results: Skeletal Muscle -- 6.1 Direct Skeletal Muscle Damage. -- 6.2 Muscular Dystrophies. -- 6.3 Hypothyroidism. -- 6.4 Various Muscular Diseases. -- 6.5 Collagen Diseases. -- 7 Clinical Results: Central Nervous System -- 7.1 Cerebral Diseases. -- 7.2 Acute Psychosis. -- 8 Clinical Results: Gastrointestinal Tract, Liver, and Pancreas. -- 8.1 Gastrointestinal Tract Diseases -- 8.2 Liver Diseases -- 8.3 Pancreatic Diseases -- 9 Clinical Results: Kidney and Urogenital Tract. -- 9.1 Renal Diseases -- 9.2 Prostatic Carcinoma -- 10 Clinical Results: Intoxication -- 10.1 Exogenous Intoxication. -- 10.2 Alcoholism. -- 11 Clinical Results: Perinatal Period. -- 11.1 Enzymes in Pregnancy -- 11.2 Myometrium and Placenta -- 11.3 Maternal Serum During Pregnancy, Labor, and After Delivery -- 11.4 Cord Blood -- 11.5 Discussion -- 11.6 Summary -- 12 The Creatine Kinase 242 BB Isoenzyme. -- 12.1 Distribution ofCK-BB in Human Tissues -- 12.2 Problems in Evaluation of Published Data -- 12.3 Serum CK-BB Activity -- 12.4 CK-BB in Cerebrospinal Fluid -- 12.5 “Idiopathic” and “Macro” Serum CK-BB -- 12.6 Genetic Variants -- 12.7 Summary -- References -- List of Abbreviations.
|
| 650 |
|
0 |
|a Human physiology.
|
| 650 |
|
0 |
|a Biochemistry.
|
| 650 |
|
0 |
|a Pathology.
|
| 650 |
1 |
4 |
|a Human Physiology.
|
| 650 |
2 |
4 |
|a Biochemistry, general.
|
| 650 |
2 |
4 |
|a Pathology.
|
| 700 |
1 |
|
|a Lang, Hermann.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-68041-0
|